----

| ☒ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|---------|--------------------------------------------------------------------------------------|

| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|---------|------------------------------------------------------------------------------------------|

| Delaware(State or other jurisdiction of incorporation or organization)                  |   | 84-290924(I.R.S. Employer Identification No.) |
|-----------------------------------------------------------------------------------------|--------|-----------------------------------------------|
|                                                                                    |   |                                          |
| 25 Deforest Avenue, Suite 108Summit, New Jersey(Address of principal executive offices) |   | 07901(Zip Code)                               |

| Title of each class                                                                                                                         |   | Trading Symbol |   | Name of each exchange on which registered |
|---------------------------------------------------------------------------------------------------------------------------------------------|--------|----------------|--------|-------------------------------------------|
|                                                                                                                                        |   |           |   |                                      |
| Units, each consisting of one share of Class A common stock, $0.0001 par value, and one-half of one redeemable warrant                      |   | CHPMU          |   | The Nasdaq Stock Market LLC               |
|                                                                                                                                        |   |           |   |                                      |
| Redeemable common stock included as part of the units                                                                                       |   | CHPM           |   | The Nasdaq Stock Market LLC               |
|                                                                                                                                        |   |           |   |                                      |
| Warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 |   | CHPMW          |   | The Nasdaq Stock Market LLC               |

| ☐ Yes  ☒ No | Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. |
|------------------------------|-------------------------------------------------------------------------------------------------------------------------|

----

| ☐ Yes  ☒ No | Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. |
|------------------------------|------------------------------------------------------------------------------------------------------------------------------|

| Large accelerated filer | Accelerated filer | Non‐accelerated filer | Smaller reporting company | Emerging growth company |
|-------------------------|-------------------|-----------------------------|---------------------------|-------------------------|
| ☐                 | ☐           | ☒                     | ☒                   | ☒                 |

----

----

| PART I   | 2                                                                                                                                 |
|----------|-----------------------------------------------------------------------------------------------------------------------------------|
|     | Item 1.  Business                                                                                                            | 2 |
|     | Item 1A.  Risk Factors.                                                                                                      | 14 |
|     | Item 1B.  Unresolved Staff Comments                                                                                          | 42 |
|     | Item 2.  Properties                                                                                                          | 42 |
|     | Item 3.  Legal Proceedings                                                                                                   | 42 |
|     | Item 4.  Mine Safety Disclosures                                                                                             | 42 |
| PART II  | 43                                                                                                                                |
|     | Item 5.  Market for Registrant’s Common Equity, Related Stockholder Matters and Issuers Purchases of Equity Securities | 43 |
|     | Item 6.  Selected Financial Data                                                                                             | 43 |
|     | Item 7.  Management’s Discussion and Analysis of Financial Condition and Results of Operations                         | 44 |
|     | Item 7A.  Quantitative and Qualitative Disclosures About Market Risk                                                         | 47 |
|     | Item 8.  Consolidated Financial Statements and Supplementary Data                                                            | 48 |
|     | Item 9.  Changes in and Disagreements with Accountants on Accounting and Financial Disclosure                                | 48 |
|     | Item 9A.  Controls and Procedures                                                                                            | 48 |
|     | Item 9B.  Other Information                                                                                                  | 48 |
| PART III | 49                                                                                                                                |
|     | Item 10.  Directors, Executive Officers, and Corporate Governance                                                            | 49 |
|     | Item 11.  Executive Compensation                                                                                             | 54 |
|     | Item 12.  Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters                     | 54 |
|     | Item 13.  Certain Relationships and Related Transactions, and Director Independence                                          | 57 |
|     | Item 14.  Principal Accountant Fees and Services                                                                             | 58 |
| PART IV  | 59                                                                                                                                |
|     | Item 15.  Exhibits and Financial Statement Schedules                                                                         | 59 |
|     | Item 16.  Form 10-K Summary                                                                                                  | 60 |

----

Table of Contents

|  | • | our ability to select an appropriate target business or businesses; |
|--|---------|---------------------------------------------------------------------|

|  | • | our ability to complete our initial business combination; |
|--|---------|-----------------------------------------------------------|

|  | • | our expectations around the performance of a prospective target business or businesses; |
|--|---------|-----------------------------------------------------------------------------------------|

|  | • | our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination; |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination; |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | our potential ability to obtain additional financing to complete our initial business combination; |
|--|---------|----------------------------------------------------------------------------------------------------|

|  | • | our pool of prospective target businesses, including the location and industry of such target businesses; |
|--|---------|-----------------------------------------------------------------------------------------------------------|

|  | • | the ability of our officers and directors to generate a number of potential business combination opportunities; |
|--|---------|-----------------------------------------------------------------------------------------------------------------|

|  | • | our public securities’ potential liquidity and trading; |
|--|---------|---------------------------------------------------------------|

|  | • | the lack of an active trading market for our securities; |
|--|---------|----------------------------------------------------------|

|  | • | the use of proceeds not held in the trust account or available to us from interest income on the trust account balance; |
|--|---------|-------------------------------------------------------------------------------------------------------------------------|

|  | • | the trust account not being subject to claims of third parties; or |
|--|---------|--------------------------------------------------------------------|

|  | • | our financial performance. |
|--|---------|----------------------------|

----

Table of Contents

| Item 1. | Business |
|---------|----------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

|  | • | Established companies with proven track records, but opportunities for operational improvements |
|--|---------|-------------------------------------------------------------------------------------------------|

|  | • | Innovative products or services that meet market needs (lower costs and / or improve quality) |
|--|---------|-----------------------------------------------------------------------------------------------|

|  | • | Solid leadership with significant knowledge of target markets |
|--|---------|---------------------------------------------------------------|

|  | • | Strong competitive position |
|--|---------|-----------------------------|

|  | • | Ability to enhance growth and scale through strategic partnerships and could benefit from the relationships and experience of our management team and Concord |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | Reliable demand that will drive recurring revenue |
|--|---------|---------------------------------------------------|

|  | • | Opportunities for bolt-on acquisitions |
|--|---------|----------------------------------------|

|  | • | Appropriate valuation |
|--|---------|-----------------------|

|  | • | Benefit from being a public company |
|--|---------|-------------------------------------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

|  | • | conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers; and |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------|

|  | • | file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about the initial business combination and the redemption rights as is                required under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies. |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender offer rules; and |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | file proxy materials with the SEC. |
|--|---------|------------------------------------|

----

Table of Contents

|  | • | conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender offer rules; and |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | file proxy materials with the SEC. |
|--|---------|------------------------------------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

| Item 1A. | Risk Factors. |
|----------|---------------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

|  | • | a limited availability of market quotations for our securities; |
|--|---------|-----------------------------------------------------------------|

|  | • | reduced liquidity for our securities; |
|--|---------|---------------------------------------|

|  | • | a determination that our Class A common stock is a “penny stock” which will require brokers trading in our Class A common stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary                trading market for our securities; |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | a limited amount of news and analyst coverage; and |
|--|---------|----------------------------------------------------|

|  | • | a decreased ability to issue additional securities or obtain additional financing in the future. |
|--|---------|--------------------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

|  | • | restrictions on the nature of our investments; and |
|--|---------|----------------------------------------------------|

|  | • | restrictions on the issuance of securities; |
|--|---------|---------------------------------------------|

|  | • | registration as an investment company with the SEC; |
|--|---------|-----------------------------------------------------|

|  | • | adoption of a specific form of corporate structure; and |
|--|---------|---------------------------------------------------------|

|  | • | reporting, record keeping, voting, proxy and disclosure requirements and compliance with other rules and regulations that we are currently not subject to. |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

|  | • | may significantly dilute the equity interest of investors in the initial public offering, which dilution would increase if the anti-dilution provisions in the founder shares resulted in the issuance of shares of Class A common stock on a                greater than one-to-one basis upon conversion of the founder shares; |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | may subordinate the rights of holders of common stock if preferred stock is issued with rights senior to those afforded our common stock; |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | could cause a change in control if a substantial number of common stock is issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of                our present officers and directors; |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | may have the effect of delaying or preventing a change of control of us by diluting the stock ownership or voting rights of a person seeking to obtain control of us; and |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | may adversely affect prevailing market prices for our units, Class A common stock and/or warrants. |
|--|---------|----------------------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

|  | • | default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations; |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver                or renegotiation of that covenant; |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand; |
|--|---------|--------------------------------------------------------------------------------------------------------|

|  | • | our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding; |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | our inability to pay dividends on our common stock; |
|--|---------|-----------------------------------------------------|

----

Table of Contents

|  | • | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our common stock if declared, expenses, capital expenditures, acquisitions and other general                corporate purposes; |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------|

|  | • | increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who                have less debt. |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | solely dependent upon the performance of a single business, property or asset; or |
|--|---------|-----------------------------------------------------------------------------------|

|  | • | dependent upon the development or market acceptance of a single or limited number of products, processes or services. |
|--|---------|-----------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

|  | • | costs and difficulties inherent in managing cross-border business operations and complying with commercial and legal requirements of overseas markets; |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | rules and regulations regarding currency redemption; |
|--|---------|------------------------------------------------------|

|  | • | complex corporate withholding taxes on individuals; |
|--|---------|-----------------------------------------------------|

|  | • | laws governing the manner in which future business combinations may be effected; |
|--|---------|----------------------------------------------------------------------------------|

|  | • | tariffs and trade barriers; |
|--|---------|-----------------------------|

|  | • | regulations related to customs and import/export matters; |
|--|---------|-----------------------------------------------------------|

|  | • | longer payment cycles; |
|--|---------|------------------------|

|  | • | tax consequences, such as tax law changes, including termination or reduction of tax and other incentives that the applicable government provides to domestic companies, and variations in tax laws as compared to the United States; |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | currency fluctuations and exchange controls; |
|--|---------|----------------------------------------------|

|  | • | rates of inflation; |
|--|---------|---------------------|

----

Table of Contents

|  | • | challenges in collecting accounts receivable; |
|--|---------|-----------------------------------------------|

|  | • | cultural and language differences; |
|--|---------|------------------------------------|

|  | • | employment regulations; |
|--|---------|-------------------------|

|  | • | crime, strikes, riots, civil disturbances, terrorist attacks, natural disasters and wars; |
|--|---------|-------------------------------------------------------------------------------------------|

|  | • | deterioration of political relations with the United States; |
|--|---------|--------------------------------------------------------------|

|  | • | obligatory military service by personnel; and |
|--|---------|-----------------------------------------------|

|  | • | government appropriation of assets. |
|--|---------|-------------------------------------|

| Item 1B. | Unresolved Staff Comments |
|----------|---------------------------|

| Item 2. | Properties |
|---------|------------|

| Item 3. | Legal Proceedings |
|---------|-------------------|

| Item 4. | Mine Safety Disclosures |
|---------|-------------------------|

----

Table of Contents

| Item 5. | Market for Registrant’s Common Equity, Related Stockholder Matters and Issuers Purchases of Equity Securities |
|---------|---------------------------------------------------------------------------------------------------------------------|

| Item 6. | Selected Financial Data |
|---------|-------------------------|

----

Table of Contents

| Item 7. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
|---------|---------------------------------------------------------------------------------------------|

|  | • | may significantly dilute the equity interest of investors, which dilution would increase if the anti-dilution provisions in the founder shares resulted in the issuance of shares of Class A common stock on a greater than one-to-one basis                upon conversion of the founder shares; |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | may subordinate the rights of holders of common stock if preferred stock is issued with rights senior to those afforded our common stock; |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | could cause a change in control if a substantial number of shares of our common stock are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation                or removal of our present officers and directors; |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | may have the effect of delaying or preventing a change of control of us by diluting the stock ownership or voting rights of a person seeking to obtain control of us; and |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | may adversely affect prevailing market prices for our units, Class A common stock and/or warrants. |
|--|---------|----------------------------------------------------------------------------------------------------|

|  | • | default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations; |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver                or renegotiation of that covenant; |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand; |
|--|---------|--------------------------------------------------------------------------------------------------------|

|  | • | our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding; |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | our inability to pay dividends on our common stock; |
|--|---------|-----------------------------------------------------|

----

Table of Contents

|  | • | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our common stock if declared, expenses, capital expenditures, acquisitions and other general                corporate purposes; |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------|

|  | • | increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who                have less debt. |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

| Item 7A. | Quantitative and Qualitative Disclosures About Market Risk |
|----------|------------------------------------------------------------|

----

Table of Contents

| Item 8. | Consolidated Financial Statements and Supplementary Data |
|---------|----------------------------------------------------------|

| Item 9. | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure |
|---------|--------------------------------------------------------------------------------------|

| Item 9A. | Controls and Procedures |
|----------|-------------------------|

| Item 9B. | Other Information |
|----------|-------------------|

----

Table of Contents

| Item 10. | Directors, Executive Officers, and Corporate Governance |
|----------|---------------------------------------------------------|

| Name              |   | Age    |   | Title                                |
|-------------------|--------|--------|--------|--------------------------------------|
|              |   |   |   |                                 |
| Joseph R. Swedish |   | 68     |   | Chairman                             |
|              |   |   |   |                                 |
| James T. Olsen    |   | 48     |   | Chief Executive Officer and Director |
|              |   |   |   |                                 |
| Benson Jose       |   | 40     |   | Chief Financial Officer              |
|              |   |   |   |                                 |
| James A. Deal     |   | 69     |   | Director                             |
|              |   |   |   |                                 |
| Ken Goulet        |   | 60     |   | Director                             |
|              |   |   |   |                                 |
| Jack Krouskup     |   | 70     |   | Director                             |

----

Table of Contents

----

Table of Contents

----

Table of Contents

|  | • | the appointment, compensation, retention, replacement, and oversight of the work of the independent registered public accounting firm and any other independent registered public accounting firm engaged by us; |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | pre-approving all audit and non-audit services to be provided by the independent registered public accounting firm or any other registered public accounting firm engaged by us, and establishing pre-approval policies and procedures; |
|--|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | reviewing and discussing with the independent registered public accounting firm all relationships the auditors have with us in order to evaluate their continued independence; |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | setting clear hiring policies for employees or former employees of the independent registered public accounting firm; |
|--|---------|-----------------------------------------------------------------------------------------------------------------------|

|  | • | setting clear policies for audit partner rotation in compliance with applicable laws and regulations; |
|--|---------|-------------------------------------------------------------------------------------------------------|

|  | • | obtaining and reviewing a report, at least annually, from the independent registered public accounting firm describing (1) the independent auditor’s internal quality-control procedures and (2) any material issues raised by the most                  recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities, within the preceding five years respecting one or more independent audits carried                  out by the firm and any steps taken to deal with such issues; |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | reviewing with management, the independent registered public accounting firm, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and                  any employee complaints or published reports that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting                  Standards Board, the SEC or other regulatory authorities. |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

|  | • | reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer’s compensation, evaluating our Chief Executive Officer’s performance in light of such goals and objectives and                  determining and approving the remuneration (if any) of our Chief Executive Officer based on such evaluation; |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | reviewing and approving the compensation of all of our other officers; |
|--|---------|------------------------------------------------------------------------|

|  | • | reviewing our executive compensation policies and plans; |
|--|---------|----------------------------------------------------------|

|  | • | implementing and administering our incentive compensation equity-based remuneration plans; |
|--|---------|--------------------------------------------------------------------------------------------|

|  | • | assisting management in complying with our proxy statement and annual report disclosure requirements; |
|--|---------|-------------------------------------------------------------------------------------------------------|

|  | • | approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our officers and employees; |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | producing a report on executive compensation to be included in our annual proxy statement; and |
|--|---------|------------------------------------------------------------------------------------------------|

|  | • | reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors. |
|--|---------|----------------------------------------------------------------------------------------------------|

----

Table of Contents

| Item 11. | Executive Compensation |
|----------|------------------------|

| Item 12. | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters |
|----------|------------------------------------------------------------------------------------------------|

|  | • | each person known by us to be the beneficial owner of more than 5% of our outstanding shares of common stock; |
|--|---------|---------------------------------------------------------------------------------------------------------------|

|  | • | each of our executive officers, directors and director nominees; and |
|--|---------|----------------------------------------------------------------------|

|  | • | all our executive officers, directors and director nominees as a group. |
|--|---------|-------------------------------------------------------------------------|

----

Table of Contents

|                                                                               |   | Class A Common Stock               |      |   | Class B Common Stock(2)         |   |    |                                |   |
|------------------------------------------------------------------------------------|--------|------------------------------------|-----------|--------|---------------------------------|--------|---------|-------------------------------------|--------|
|  Name of Beneficial Owner                                                     |   | Number of SharesBeneficially Owned |      |   | Approximate Percentage of Class |   |    | Number of Shares Beneficially Owned |   |   | Approximate Percentage of Class |   |   | Approximate Percentage of Outstanding Common Stock |   |
| CHP Acquisition Holdings LLC (our sponsor)(1)(3)                                   |   |                               | —   |   |                            |   | — |                                |   |   | 7,425,000 |   |   |   | 99.0 | % |   |   | 19.8 | % |
| Joseph Swedish(1)(3)                                                               |   |                               | —   |   |                            |   | — |                                |   |   | 7,425,000 |   |   |   | 99.0 | % |   |   | 19.8 | % |
| James Olsen(1)(3)                                                                  |   |                               | —   |   |                            |   | — |                                |   |   | 7,425,000 |   |   |   | 99.0 | % |   |   | 19.8 | % |
| Benson Jose(1)                                                                     |   |                               | —   |   |                            |   | — |                                |   |   | — |   |   |   | — |   |   |   | — |   |
| James A. Deal(1)                                                                   |   |                               | —   |   |                            |   | — |                                |   |   | 25,000 |   |   |   | * |   |   |   | * |   |
| Ken Goulet(1)                                                                      |   |                               | —   |   |                            |   | — |                                |   |   | 25,000 |   |   |   | * |   |   |   | * |   |
| Jack Krouskup(1)                                                                   |   |                               | —   |   |                            |   | — |                                |   |   | 25,000 |   |   |   | * |   |   |   | * |   |
| Magnetar Financial LLC(4)                                                          |   |                               | 2,450,000 |   |                            |   | 8.2     | %                                   |   |   | — |   |   |   | — |   |   |   | 6.5 | % |
| UBS O’Connor LLC(5)                                                          |   |                               | 2,450,000 |   |                            |   | 8.2     | %                                   |   |   | — |   |   |   | — |   |   |   | 6.5 | % |
| Manulife Financial Corporation(6)                                                  |   |                               | 2,100,000 |   |                            |   | 7.0     | %                                   |   |   | — |   |   |   | — |   |   |   | 5.6 | % |
| Linden Capital(7)                                                                  |   |                               | 2,062,900 |   |                            |   | 6.9     | %                                   |   |   | — |   |   |   | — |   |   |   | 5.5 | % |
| Millennium Group Management LLC(8)                                                 |   |                               | 2,000,000 |   |                            |   | 6.7     | %                                   |   |   | — |   |   |   | — |   |   |   | 5.3 | % |
| HGC Investment Management Inc.(9)                                                  |   |                               | 1,967,230 |   |                            |   | 6.6     | %                                   |   |   | — |   |   |   | — |   |   |   | 5.2 | % |
| All directors, director nominees and executive officers as a group (6 individuals) |   |                               | —   |   |                            |   | — |                                |   |   | — |   |   |   | 100.0 | % |   |   | 20 | % |

| * | Less than one percent. |
|---|------------------------|

| (1) | Unless otherwise noted, the business address of each of the following entities or individuals is 25 Deforest Avenue, Suite 108, Summit NJ 07901. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | Interests shown consist solely of founder shares. Such shares will automatically convert into shares of Class A common stock at the time of our initial business combination on a one-for-one basis, subject to adjustment. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

| (3) | Represents 7,425,000 founder shares held of record by CHP Acquisition Holdings LLC, which is wholly-owned by Concord Health Partners LLC. Messrs. Swedish and Olsen control Concord Health Partners LLC, which is the managing member of                  our sponsor. Each of CHP Acquisition Holdings LLC, Concord Health Partners LLC and Messrs. Swedish and Olsen shares voting and dispositive power over these shares. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (4) | Based on a Schedule 13G filed by Magnetar Financial LLC, Magnetar Capital Partners LP, Supernova Management LLC and Alec N. Litowitz with the SEC on February 13, 2020. Each of Magnetar Financial LLC, Magnetar Capital Partners LP,                  Supernova Management LLC and Alec N. Litowitz has shared voting and shared dispositive power over the shares, consisting of (i) 793,920 held for the account of                    Constellation Master Fund; (ii) 329,492 held for the account of Xing He Master Fund; (iii) 746,212 held for the account of Constellation Fund; (iv) 164,036 held for the account of SC Fund; and (v) 416,340 held of the account of                    Structured Credit Fund. The principal business address of each of Magnetar Financial, Magnetar Capital Partners, Supernova Management, and Mr. Litowitz is 1603 Orrington Avenue, 13th Floor, Evanston, Illinois 60201. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (5) | Based on a Schedule 13G filed by UBS O’Connor LLC with the SEC on February 13, 2020. UBS O’Connor LLC exercises sole voting and dispositive power over 2,450,000 shares. The principal business address of the beneficial owner is One                  North Wacker Drive, 32nd Floor, Chicago, Illinois 60606. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (6) | Based on a Schedule 13G filed by Manulife Financial Corporation and Manulife Investment Management Limited with the SEC on February 12, 2020. Manulife Investment Management Limited has sole voting and dispositive power over the shares.                  Through its parent-subsidiary relationship to Manulife Investment Management Limited, Manulife Financial Corporation may be deemed to have beneficial ownership of the shares. The principal business address of the beneficial owners is 200                  Bloor Street East, Toronto, Ontario, Canada, M4W 1E5. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (7) | Based on a Schedule 13G/A filed by Linden Capital L.P., Linden GP LLC, Linden Advisors LP and Siu Min Wong with the SEC on January 14, 2020. Each of Linden Advisors and Mr. Wong may be deemed the beneficial owner of 2,062,900 shares.                  This amount consists of 1,842,481 shares held by Linden Capital L.P. and 220,419 shares held by separately managed accounts. Each of Linden GP LLC and Linden Capital L.P. may be deemed the beneficial owners of the 1,842,481 shares held by                  Linden Capital L.P. The principal business address for Linden Capital is Victoria Place, 31 Victoria Street, Hamilton HM10, Bermuda. The principal business address for each of Linden Advisors, Linden GP and Mr. Wong is 590 Madison Avenue,                  15th Floor, New York, New York 10022. |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (8) | Based on a Schedule 13G filed by Integrated Core Strategies (US) LLC, Riverview Group LLC, ICS Opportunities, Ltd., Millennium International Management LP, Millennium Management LLC, Millennium Group Management LLC and Israel A.                  Englander with the SEC on December 2, 2019. Each of Integrated Core Strategies (US) LLC, ICS Opportunities, Ltd. and Millennium International Management LP has shared voting and shared dispositive power over 500,000 shares. Riverview                  Group LLC has shared voting and shared dispositive power over 1,000,000 shares. Each of Millennium Management LLC, Millennium Group Management LLC and Israel a. Englander has shared voting and shared dispositive power over 2,000,000                  shares. The principal business address of Millennium Group Management LP, Millennium Management LLC and Israel Englander is 666 Fifth Avenue, New York, New York 10103. |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (9) | Based on a Schedule 13G filed by HGC Investment Management Inc. with the SEC on February 14, 2020. HGC Investment Management Inc. exercises sole voting and sole dispositive power over 1,967,230 shares. The principal business address of                  the beneficial owner is 366 Adelaide, Suite 601, Toronto, Ontario M5V 1R9, Canada. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

| Item 13. | Certain Relationships and Related Transactions, and Director Independence |
|----------|---------------------------------------------------------------------------|

----

Table of Contents

|  | • | Repayment of an aggregate of up to $300,000 in loans made to us by our sponsor to cover offering-related and organizational expenses; |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------|

|  | • | Payment to an affiliate of our sponsor of a total of $10,000 per month, for up to 24 months for office space, utilities, administrative and support services; |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | Reimbursement for any out-of-pocket expenses related to identifying, investigating and completing an initial business combination; and |
|--|---------|----------------------------------------------------------------------------------------------------------------------------------------|

|  | • | Repayment of loans which may be made by our sponsor or an affiliate of our sponsor or certain of our officers and directors to finance transaction costs in connection with an intended initial business combination, the terms of which                  have not been determined nor have any written agreements been executed with respect thereto. Up to $1,500,000 of such loans may be convertible into warrants at a price of $1.00 per warrant at the option of the lender. |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Item 14. | Principal Accountant Fees and Services |
|----------|----------------------------------------|

----

Table of Contents

| Item 15. | Exhibits and Financial Statement Schedules |
|----------|--------------------------------------------|

| (a) | The following documents are filed as part of this Form 10-K: |
|-----|--------------------------------------------------------------|

| (1) | Financial Statements: |
|-----|-----------------------|

|                                                    | Page |
|---------------------------------------------------------|------|
| Report of Independent Registered Public Accounting Firm | F-2  |
| Balance Sheet                                           | F-3  |
| Statement of Operations                                 | F-4  |
| Statement of Changes in Stockholder’s Equity      | F-5  |
| Statement of Cash Flows                                 | F-6  |
| Notes to Financial Statements                           | F-7  |

| (2) | Financial Statement Schedules: |
|-----|--------------------------------|

| (3) | Exhibits |
|-----|----------|

| Exhibit              Number |   | Description of Exhibit                                                                                                                                                                                                                       |
|-----------------------------|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 3.1                         |   | Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed on November 27, 2019 (File No. 001-39140))                                                   |
|                        |   |                                                                                                                                                                                                                                              |
| 4.1                         |   | Warrant Agreement between Continental Stock Transfer & Trust Company and the Company (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed on November 27, 2019 (File No. 001-39140))            |
|                        |   |                                                                                                                                                                                                                                              |
| 4.2                         |   | Specimen Class A Common Stock Certificate (incorporated by reference to Exhibit 4.2 to the amendment to the Company’s form S-1, filed on November 13, 2019, (File No. 333-234413))                                                          |
|                        |   |                                                                                                                                                                                                                                              |
| 4.3                         |   | Specimen Warrant Certificate. (incorporated by reference to Exhibit 4.3 to the amendment to the Company’s form S-1, filed on November 13, 2019, (File No. 333-234413))                                                                      |
|                        |   |                                                                                                                                                                                                                                              |
| 4.4                         |   | Form of Warrant Agreement between Continental Stock Transfer & Trust Company and the Company (incorporated by reference to Exhibit 4.4 to the amendment to the Company’s form S-1, filed on November 13, 2019, (File No. 333-234413))   |
|                        |   |                                                                                                                                                                                                                                              |
| 4.5*                        |   | Description of Registrant’s Securities                                                                                                                                                                                                      |
|                        |   |                                                                                                                                                                                                                                              |
| 10.1                        |   | Private placement warrants Purchase Agreement between the Company and CHP Acquisition Holdings LLC (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed on November 27, 2019 (File No. 001-39140)) |

----

Table of Contents

| 10.2   |   | Investment Management trust account Agreement between Continental Stock Transfer & Trust Company and the Company (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K, filed on November 27, 2019 (File              No. 001-39140))           |
|--------|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                                                                                                                                                       |
| 10.3   |   | Registration Rights Agreement between the Company and CHP Acquisition Holdings LLC (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K, filed on November 27, 2019 (File No. 001-39140))                                                          |
|   |   |                                                                                                                                                                                                                                                                                       |
| 10.4   |   | Letter Agreement between the Company and CHP Acquisition Holdings LLC, each of the officers and directors of the Company (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K, filed on November 27, 2019              (File No. 001-39140))       |
|   |   |                                                                                                                                                                                                                                                                                       |
| 10.5   |   | Administrative Services Agreement between the Company and Concord Health Partners LLC (incorporated by reference to Exhibit 10.5 to the Company’s Current Report on Form 8-K, filed on November 27, 2019 (File No. 001-39140))                                                       |
|   |   |                                                                                                                                                                                                                                                                                       |
| 10.6+  |   | Form of Indemnity Agreement, dated November 21, 2019, between the Company and each of the officers and directors of the Company(incorporated by reference to Exhibit 10.6 to the Company’s Current Report on Form 8-K, filed on November 27,              2019 (File No. 001-39140)) |
|   |   |                                                                                                                                                                                                                                                                                       |
| 24     |   | Powers of Attorney (included in signature page to the Company’s Registration Statement (File No. 333-234413) filed on October 31, 2019.                                                                                                                                              |
|   |   |                                                                                                                                                                                                                                                                                       |
| 31.1*  |   | Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002                                                                                                     |
|   |   |                                                                                                                                                                                                                                                                                       |
| 31.2*  |   | Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002                                                                                                     |
|   |   |                                                                                                                                                                                                                                                                                       |
| 32.1** |   | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.                                                                                                                                     |
|   |   |                                                                                                                                                                                                                                                                                       |
| 32.2** |   | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.                                                                                                                                     |

----

| * | Filed herewith. |
|---|-----------------|

| ** | Furnished herewith |
|----|--------------------|

| + | Indicates a management contract or compensatory plan. |
|---|-------------------------------------------------------|

| Item 16. | Form 10-K Summary |
|----------|-------------------|

----

Table of Contents

|   | By:    | /s/ James T. Olsen             |   |
|--------|--------|--------------------------------|--------|
|   |   | Name: James T. Olsen           |
|   |   | Title: Chief Executive Officer |

| Signature             |   | Title                   |   | Date           |
|-----------------------|--------|-------------------------|--------|----------------|
|                  |   |                    |   |           |
| /s/ James T. Olsen    |   | Chief Executive Officer |   | March 23, 2020 |
| James T. Olsen        |   |                    |   |           |
|                  |   |                    |   |           |
| /s/ Benson Jose       |   | Chief Financial Officer |   | March 23, 2020 |
| Benson Jose           |   |                    |   |           |
|                  |   |                    |   |           |
| /s/ Joseph R. Swedish |   | Chairman of the Board   |   | March 23, 2020 |
| Joseph R. Swedish     |   |                    |   |           |
|                  |   |                    |   |           |
| /s/ James A. Deal     |   | Director                |   | March 23, 2020 |
| James A. Deal         |   |                    |   |           |
|                  |   |                    |   |           |
| /s/ Ken Goulet        |   | Director                |   | March 23, 2020 |
| Ken Goulet            |   |                    |   |           |
|                  |   |                    |   |           |
| /s/ Jack Krouskup     |   | Director                |   | March 23, 2020 |
| Jack Krouskup         |   |                    |   |           |

----

Table of Contents

| Report of Independent Registered Public Accounting Firm | F-2         |
|---------------------------------------------------------|-------------|
| Financial Statements:                                   |        |
| Balance Sheet                                           | F-3         |
| Statement of Operations                                 | F-4         |
| Statement of Changes in Stockholders’ Equity      | F-5         |
| Statement of Cash Flows                                 | F-6         |
| Notes to Financial Statements                           | F-7 to F-17 |

----

Table of Contents

----

Table of Contents

| ASSETS                                                                                                                                                                       |   |   |        |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------|-------------|
| Current assets                                                                                                                                                               |   |   |        |
| Cash                                                                                                                                                                         |   | $      | 1,301,607   |   |
| Prepaid expenses and other current assets                                                                                                                                    |   |   | 103,344     |   |
| Total Current Assets                                                                                                                                                         |   |   | 1,404,951   |   |
|                                                                                                                                                                         |   |   |        |   |
| Marketable securities held in trust account                                                                                                                                  |   |   | 300,427,494 |   |
| Total Assets                                                                                                                                                                 |   | $      | 301,832,445 |   |
|                                                                                                                                                                         |   |   |        |   |
| LIABILITIES AND STOCKHOLDERS’ EQUITY                                                                                                                                   |   |   |        |   |
| Current liabilities                                                                                                                                                          |   |   |        |   |
| Accounts payable and accrued expenses                                                                                                                                        |   | $      | 121,753     |   |
| Income taxes payable                                                                                                                                                         |   |   | 72,043      |   |
| Total Current Liabilities                                                                                                                                                    |   |   | 193,796     |   |
|                                                                                                                                                                         |   |   |        |   |
| Deferred underwriting fee payable                                                                                                                                            |   |   | 10,500,000  |   |
| Total Liabilities                                                                                                                                                            |   |   | 10,693,796  |   |
|                                                                                                                                                                         |   |   |        |   |
| Commitments and contingencies                                                                                                                                                |   |   |        |   |
|                                                                                                                                                                         |   |   |        |   |
| Common stock subject to possible redemption, 28,613,864 shares at redemption value                                                                                           |   |   | 286,138,640 |   |
|                                                                                                                                                                         |   |   |        |   |
| Stockholders’ Equity                                                                                                                                                   |   |   |        |   |
| Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding                                                                                  |   |   | —     |   |
| Class A common stock, $0.0001 par value; 200,000,000 shares authorized; 1,386,136 shares issued and outstanding (excluding 28,613,864 shares subject to possible redemption) |   |   | 139         |   |
| Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 7,500,000 shares issued and outstanding(1)                                                            |   |   | 750         |   |
| Additional paid-in capital                                                                                                                                                   |   |   | 4,814,609   |   |
| Retained earnings                                                                                                                                                            |   |   | 184,511     |   |
| Total Stockholders’ Equity                                                                                                                                             |   |   | 5,000,009   |   |
| Total Liabilities and Stockholders’ Equity                                                                                                                             |   | $      | 301,832,445 |   |

|  | (1) | On November 21, 2019, the Company effected a stock dividend of 718,750 Founder Shares, resulting in our Sponsor holding an aggregate of 7,906,250 Founder Shares. All share and per-share amounts have been retroactively restated.                  Additionally, in connection with the underwriter’s partial exercise of the over-allotment option and the forfeiture of the remaining over-allotment option, 406,250 Founder Shares were forfeited and 625,000 Founder Shares are no longer                  subject to forfeiture. |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

|                                                                          |   |   |       |
|-------------------------------------------------------------------------------|--------|--------|------------|
| General and administrative expenses                                           |   | $      | 170,940    |   |
| Loss from operations                                                          |   |   | (170,940   | ) |
|                                                                          |   |   |       |   |
| Other income:                                                                 |   |   |       |   |
| Interest earned on marketable securities held in trust account                |   |   | 427,494    |   |
|                                                                          |   |   |       |   |
| Income before provision for income taxes                                      |   |   | 256,554    |   |
| Provision for income taxes                                                    |   |   | (72,043    | ) |
| Net income                                                                    |   | $      | 184,511    |   |
|                                                                          |   |   |       |   |
| Weighted average shares outstanding of Class A redeemable common stock        |   |   | 30,000,000 |   |
| Basic and diluted income per share, Class A                                   |   | $      | 0.01       |   |
|                                                                          |   |   |       |   |
| Weighted average shares outstanding of Class B non-redeemable common stock(1) |   |   | 7,795,706  |   |
| Basic and diluted net income per share, Class B                               |   | $      | (0.01      | ) |

|  | (1) | On November 21, 2019, the Company effected a stock dividend of 718,750 Founder Shares, resulting in our Sponsor holding an aggregate of 7,906,250 Founder Shares. All share and per-share amounts have been retroactively restated.                  Additionally, in connection with the underwriter’s partial exercise of the over-allotment option and the forfeiture of the remaining over-allotment option, 406,250 Founder Shares were forfeited and 625,000 Founder Shares are no longer                  subject to forfeiture. |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

|                                                                         |   |                 |        |   |                 |   |    |                            |   |   |      |   |   |                                        |    |   |     |   |         |        |   |
|------------------------------------------------------------------------------|--------|----------------------|-------------|--------|----------------------|--------|---------|---------------------------------|--------|--------|-----------|--------|--------|----------------------------------------|---------|--------|----------|--------|--------------|--------|--------|
|                                                                         |   | Class A Common Stock |        |   | Class B Common Stock |   |    | Additional              Paid in |   |   | Retained  |   |   | Total              Stockholders’ |    |
|                                                                         |   | Shares               |        |   | Amount               |   |    | Shares                          |   |   | Amount    |   |   | Capital                                |    |   | Earnings |   |         | Equity |   |
| Balance – July 31, 2019 (inception)                          |   |                 | —     |   |                 | $      | — |                            |   |   | —   |   |   | $                                      | — |   |     | $      | —      |   |   | $ | — |   |   | $ | — |   |
|                                                                         |   |                 |        |   |                 |   |    |                            |   |   |      |   |   |                                   |    |   |     |   |         |   |   |   |   |   |   |   |   |   |
| Issuance of Class B common stock to Sponsor(1)                               |   |                 | —     |   |                 |   | — |                            |   |   | 7,906,250 |   |   |                                   | 791     |   |     |   | 24,209       |   |   |   | — |   |   |   | 25,000 |   |
|                                                                         |   |                 |        |   |                 |   |    |                            |   |   |      |   |   |                                   |    |   |     |   |         |   |   |   |   |   |   |   |   |   |
| Sale of 30,000,000 Units, net of underwriting discount and offering expenses |   |                 | 30,000,000  |   |                 |   | 3,000   |                            |   |   | —   |   |   |                                   | — |   |     |   | 282,926,138  |   |   |   | — |   |   |   | 282,929,138 |   |
|                                                                         |   |                 |        |   |                 |   |    |                            |   |   |      |   |   |                                   |    |   |     |   |         |   |   |   |   |   |   |   |   |   |
| Sale of 8,000,000 Private placement warrants                                 |   |                 | —     |   |                 |   | — |                            |   |   | —   |   |   |                                   | — |   |     |   | 8,000,000    |   |   |   | — |   |   |   | 8,000,000 |   |
|                                                                         |   |                 |        |   |                 |   |    |                            |   |   |      |   |   |                                   |    |   |     |   |         |   |   |   |   |   |   |   |   |   |
| Forfeiture of Founder shares                                                 |   |                 | —     |   |                 |   | — |                            |   |   | (406,250  | )      |   |                                   | (41     | )      |     |   | 41           |   |   |   | — |   |   |   | — |   |
|                                                                         |   |                 |        |   |                 |   |    |                            |   |   |      |   |   |                                   |    |   |     |   |         |   |   |   |   |   |   |   |   |   |
| Common stock subject to possible redemption                                  |   |                 | (28,613,864 | )      |                 |   | (2,861  | )                               |   |   | —   |   |   |                                   | — |   |     |   | (286,135,779 | )      |   |   | — |   |   |   | (286,138,640 | ) |
|                                                                         |   |                 |        |   |                 |   |    |                            |   |   |      |   |   |                                   |    |   |     |   |         |   |   |   |   |   |   |   |   |   |
| Net income                                                                   |   |                 | —     |   |                 |   | — |                            |   |   | —   |   |   |                                   | — |   |     |   | —      |   |   |   | 184,511 |   |   |   | 184,511 |   |
|                                                                         |   |                 |        |   |                 |   |    |                            |   |   |      |   |   |                                   |    |   |     |   |         |   |   |   |   |   |   |   |   |   |
| Balance – December 31, 2019                             |   |                 | 1,386,136   |   |                 | $      | 139     |                            |   |   | 7,500,000 |   |   | $                                      | 750     |   |     | $      | 4,814,609    |   |   | $ | 184,511 |   |   | $ | 5,000,009 |   |

|  | (1) | On November 21, 2019, the Company effected a stock dividend of 718,750 Founder Shares, resulting in our Sponsor holding an aggregate of 7,906,250 Founder Shares. All share and per-share amounts have been retroactively restated.                  Additionally, in connection with the underwriter’s partial exercise of the over-allotment option and the forfeiture of the remaining over-allotment option, 406,250 Founder Shares were forfeited and 625,000 Founder Shares are no longer                  subject to forfeiture. |
|--|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

| Cash Flows from Operating Activities:                                         |   |   |         |
|-------------------------------------------------------------------------------|--------|--------|--------------|
| Net income                                                                    |   | $      | 184,511      |   |
| Adjustments to reconcile net income to net cash used in operating activities: |   |   |         |   |
| Interest earned on marketable securities held in trust account                |   |   | (427,494     | ) |
| Changes in operating assets and liabilities:                                  |   |   |         |   |
| Prepaid expenses and other current assets                                     |   |   | (103,344     | ) |
| Accounts payable and accrued expenses                                         |   |   | 121,753      |   |
| Income taxes payable                                                          |   |   | 72,043       |   |
| Net cash used in operating activities                                         |   |   | (152,531     | ) |
|                                                                          |   |   |         |   |
| Cash Flows from Investing Activities:                                         |   |   |         |   |
| Investment of cash into trust account                                         |   |   | (300,000,000 | ) |
| Net cash used in investing activities                                         |   |   | (300,000,000 | ) |
|                                                                          |   |   |         |   |
| Cash Flows from Financing Activities                                          |   |   |         |   |
| Proceeds from issuance of Class B common stock to Sponsor                     |   |   | 25,000       |   |
| Proceeds from sale of Units, net of underwriting discounts paid               |   |   | 294,000,000  |   |
| Proceeds from sale of Private placement warrants                              |   |   | 8,000,000    |   |
| Proceeds from promissory note – related party                           |   |   | 85,943       |   |
| Repayment of promissory note – related party                            |   |   | (85,943      | ) |
| Payment of offering costs                                                     |   |   | (570,862     | ) |
| Net cash provided by financing activities                                     |   |   | 301,454,138  |   |
|                                                                          |   |   |         |   |
| Net Change in Cash                                                            |   |   | 1,301,607    |   |
| Cash – Beginning of period                                              |   |   | —      |   |
| Cash – End of period                                                    |   | $      | 1,301,607    |   |
|                                                                          |   |   |         |   |
| Non-Cash investing and financing activities:                                  |   |   |         |   |
| Initial classification of common stock subject to possible redemption         |   | $      | 285,952,690  |   |
| Change in value of common stock subject to possible redemption                |   | $      | 185,950      |   |
| Deferred underwriting fee payable                                             |   | $      | 10,500,000   |   |

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

|  | • | in whole and not in part; |
|--|---------|---------------------------|

|  | • | at a price of $0.01 per warrant; |
|--|---------|----------------------------------|

|  | • | upon not less than 30 days’ prior written notice of redemption to each warrant holder; and |
|--|---------|--------------------------------------------------------------------------------------------------|

|  | • | if, and only if, the last reported sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and for certain issuances of                  Class A common stock and equity-linked securities as described below) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date the Company sends the notice of redemption to the warrant                  holders. |
|--|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | in whole and not in part; |
|--|---------|---------------------------|

|  | • | at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants prior to redemption and receive that number of shares, based on the redemption date and                  the fair market value of the Class A common stock; |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | if, and only if, the last reported sale price of the Class A common stock equals or exceeds $10.00 per share (as adjusted per stock splits, stock dividends, reorganizations, reclassifications, recapitalizations and the like) on the                  trading day prior to the date on which the Company sends the notice of redemption to the warrant holders; |
|--|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | if, and only if, the Private placement warrants are also concurrently exchanged at the same price (equal to a number of shares of Class A common stock) as the outstanding Public Warrants, as described above; and |
|--|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | • | if, and only if, there is an effective registration statement covering the issuance of the shares of Class A common stock (or a security other than the Class A common stock into which the Class A common stock has been converted or                  exchanged for in the event the Company is not the surviving company in the Business Combination) issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the 30-day period after written notice                  of redemption is given. |
|--|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

|                                  |   | December 31, 2019 |    |
|---------------------------------------|--------|-------------------|---------|
| Deferred tax asset                    |   |              |    |
| Organizational costs/Startup expenses |   | $                 | 18,166  |   |
| Total deferred tax asset              |   |              | 18,166  |   |
| Valuation allowance                   |   |              | (18,166 | ) |
| Deferred tax asset, net of allowance  |   | $                 | — |   |
|                          |   | December 31, 2019 |    |
|-------------------------------|--------|-------------------|---------|
| Federal                       |   |              |    |
| Current                       |   | $                 | 72,043  |   |
| Deferred                      |   |              | (18,166 | ) |
|                          |   |              |    |   |
| State                         |   |              |    |   |
| Current                       |   | $                 | — |   |
| Deferred                      |   |              | — |   |
| Change in valuation allowance |   |              | 18,166  |   |
| Income tax provision          |   | $                 | 72,043  |   |

----

Table of Contents

| Statutory federal income tax rate       |   |   | 21.0 | % |
|-----------------------------------------|--------|--------|------|---|
| State taxes, net of federal tax benefit |   |   | 0.0  | % |
| Change in valuation allowance           |   |   | 7.1  | % |
| Income tax provision                    |   |   | 28.1 | % |
|                   | Held-To-Maturity                               |   | Amortized Cost |        |   | Gross              Holding              Losses |   |   | Fair Value |   |
|-------------------|------------------------------------------------|--------|----------------|-------------|--------|------------------------------------------------|--------|--------|------------|--------|
| December 31, 2019 | U.S. Treasury Securities (Mature on 5/21/2020) |   | $              | 299,426,589 |   |                                           | $      | (9,722 | )          |   | $ | 299,416,867 |   |

| Level 1: | Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing                  information on an ongoing basis. |
|---------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Level 2: | Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. |
|---------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Level 3: | Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. |
|---------------|--------------------------------------------------------------------------------------------------------------------------------------|

----